Skip to main content

Clinical Report Addresses Management of Sickle Cell Disease in Children, Teens

Medically reviewed by Carmen Pope, BPharm. Last updated on July 22, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, July 22, 2024 -- Management of children and adolescents with sickle cell disease (SCD) requires comprehensive care from a pediatric primary care provider and a multidisciplinary team, according to a clinical report published online July 22 in Pediatrics.

Amber M. Yates, M.D., from the Baylor College of Medicine and Texas Children's Hospital in Houston, and colleagues present an overview focusing on the practical management of children and adolescents with SCD.

The authors note that SCD is a complex disorder with multisystem manifestations requiring comprehensive care from a pediatric primary care provider and a multidisciplinary SCD team. All aspects of general pediatric care should be managed by the pediatric primary care provider, and they should co-manage SCD-specific manifestations with the SCD team. The patient and family should be involved in all decisions. At least annual consultation with a multidisciplinary SCD team is strongly advised, although the extent to which the comprehensive care is delivered by a pediatric primary care provider versus the multidisciplinary specialist team will vary by community as well as family preference and the frequency and severity of SCD manifestations. Age-specific screening for disease complications is important at all SCD comprehensive visits. Education about and planning for urgent medical evaluation should be developed early and reviewed at each visit. The patient and family should be made aware that SCD is treatable but requires attention and active management to achieve optimum life outcomes.

"Improvements in care have resulted in almost all children with SCD surviving into adulthood and transitioning into adult care, which has allowed shifting the goal of care to improved quality of life," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Model Improves Diagnosis of Solid Lesions in Pancreas

MONDAY, July 22, 2024 -- A joint artificial intelligence (AI)-assisted model integrating clinical information and endoscopic ultrasonographic (EUS) images improves diagnosis of...

Socioeconomic Factors Linked to Persistently Active Rheumatoid Arthritis

MONDAY, July 22, 2024 -- Socioeconomic factors and deprivation are associated with persistently active rheumatoid arthritis (pactiveRA), according to a study published online July...

AAP Offers Guidance to Pediatricians for Preventing Child Maltreatment

MONDAY, July 22, 2024 -- In a clinical report published online July 22 in Pediatrics, recommendations are provided to clarify the pediatrician's role in preventing child...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.